Treating cancer with fewer side effects and cutting down recovery time has always been the goal. And advancements in drug delivery, especially with nanotechnology have already achieved 30% more effectiveness. Now, nanorobotics is set to take this further. Nanorobots are tiny machines, much smaller than human cells, designed to perform
Eleven Therapeutics has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 44% patents are active. Europe (EPO) is where Eleven Therapeutics has filed the maximum number of patents, followed by United States of America. Parallelly, United States of
Abogen has a total of 25 patents globally, out of which 10 have been granted. Of these 25 patents, more than 48% patents are active. Japan is where Abogen has filed the maximum number of patents, followed by Europe (EPO). Parallelly, Europe (EPO) seems to be the main focused R&D
Hortica has a total of 9 patents globally, out of which 1 have been granted. Of these 9 patents, more than 88% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Hortica. Hortica was founded
The human Microbiome is the aggregate of all microbiota (e.g. bacteria, archaea, fungi, protists and viruses) that reside on or within human tissues and bio fluids, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Nowadays, Microbiome is
Gina Life Diagnostics has a total of 11 patents globally, out of which no patents have been granted. Of these 11 patents, more than 81% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Gina
Angel Yeast has a total of 1316 patents globally, out of which 911 have been granted. Of these 1316 patents, more than 64% patents are active. China is where Angel Yeast has filed the maximum number of patents, followed by India and Europe (EPO). Parallelly, China seems to be the
Shenzhen Puyuan Technology has a total of 23 patents globally, out of which 28 have been granted. Of these 23 patents, more than 90% patents are active. China is where Shenzhen Puyuan Technology has filed all their patents. Parallelly, China seems to be the main focused R&D centre and also
Orbit Genomics has a total of 13 patents globally, out of which no patents have been granted. Of these 13 patents, more than 92% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Orbit Genomics. Orbit
Enzymotec has a total of 343 patents globally, out of which 175 have been granted. Of these 343 patents, more than 26% patents are active. The United States of America is where Enzymotec has filed the maximum number of patents, followed by Israel and China. Parallelly, Israel seems to be
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.